The Deen's List(TM)
A service of Deen Capital Management, Inc.
Vol.1 #22           Tuesday October 14 2003           3:40pm ET

Please read carefully our disclaimers at the end of this newsletter.

Market stance: BULLISH (since Oct 3 2003)

****************************** Bought COO ******************************

Cooper Companies Inc (COO)

Net buy price in managed accounts(*)... $42.01
Yesterday's close (Oct 13)............. $41.74
Net change (based on avg buy price).... +$0.27
Today's volume as of 2:49pm ET ........ 235,400 ($9.9 million)
Average daily volume................... 430,300 ($18.1 million)
This year's earnings-per-share......... $2.11 (est)
Next year's earnings-per-share......... $2.49 (est)
P/E using next year's earnings......... 16.9 (est)
Earnings growth rate, next 5 years..... 20.5% per year (est)

(*) The "Net buy price" is the total net purchase cost after commissions
for all managed accounts divided by the total number of shares.

The Cooper Companies (www.coopercos.com) is a specialty healthcare
company.  CooperVision markets a broad range of contact lenses, and
CooperSurgical markets diagnostic products, surgical instruments and
accessories to the women's healthcare market.

Here's why I bought this stock:

+ I previously bought this stock back on Sep 4 on the heels of a strong
earnings surprise.  There was a huge market reaction that day.  The stock
has since given back some of the gains of Sep 4, and I am able to buy
again today at a slightly lower price.

+ The long-term price trend is clearly up, even though the price is down
a bit from its early September highs.

+ Excellent recent sales growth:  Here are the quarterly year-to-year
sales growth rates from the last four quarters, in chronological order:
+43%, +62%, +34%, and, most recently, for the quarter ended Jul 31, +20%
to $108.4 million.

+ Excellent recent earnings-per-share growth:  Here are the quarterly EPS
figures for the last eight quarters:
Oct 02 vs Oct 01: 52c vs 41c
Jan 03 vs Jan 02: 44c vs 30c
Apr 03 vs Apr 02: 48c vs 32c
Jul 03 vs Jul 02: 58c vs 43c

+ Rising estimates:  According to recent data from First Call, the
consensus earnings estimate for FY 03 (Oct) is $2.11, up from $2.05 90
days ago; and the consensus estimate for FY 04 is $2.49, up from $2.46 90
days ago.

+ Valuation:  At 17 times next year's estimated earnings and a projected
5-year annualized earnings growth rate of 20.5%, the stock is attractively
priced.

+ History of earnings surprises:  This company has reported earnings at
least a penny ahead of estimates in three of the past four quarters.

+ The company's industry group ("Medical/Dental Supplies") has risen in
relative strength over the past six months, according to Investor's
Business Daily.

*********************** Subscription Information ***********************

Welcome to The Deen's List(TM), a new e-mail stock newsletter from Deen
Capital Management, Inc.

My intention is to inform you as quickly as is practical regarding my
stock market moves.  When I buy or sell a stock, first I take care of
client accounts, then I buy/sell for my personal account(s), and then,
third, I send out this newsletter.

Your feedback is welcome.  Send e-mail to deenslist@deencapital.com.
To subscribe or unsubscribe, include the word "subscribe" or
"unsubscribe" in the Subject line.

This newsletter is free to managed account clients.  For a limited time,
it is also free to all interested parties.

**************************** Privacy Policy ****************************

Your personal information, including your e-mail address, will be held
in confidence by Deen Capital Management, Inc.  We will not share it
with or sell it to others.

************************ IMPORTANT DISCLAIMERS *************************

* All stocks discussed in The Deen's List(TM) involve a high degree of
risk.  It should not be assumed that any stock discussed in The Deen's
List(TM) or purchased by Deen Capital Management, Inc. will be
profitable.

* Past performance is not necessarily indicative of future results.

* The information contained herein has been compiled from sources deemed
to be reliable; however, we are not responsible for its accuracy or
completeness.

************************************************************************

Ken Deen
Deen Capital Management, Inc.
PO Box 30925
Santa Barbara, CA 93130
(805) 682-1870
deenslist@deencapital.com

Copyright (C) 2003 Deen Capital Management, Inc.